Unknown

Dataset Information

0

A novel aqueous extract from rice fermented with Aspergillus oryzae and Saccharomyces cerevisiae possesses an anti-influenza A virus activity.


ABSTRACT: Human influenza virus infections occur annually worldwide and are associated with high morbidity and mortality. Hence, development of novel anti-influenza drugs is urgently required. Rice Power® extract developed by the Yushin Brewer Co. Ltd. is a novel aqueous extract of rice obtained via saccharization and fermentation with various microorganisms, such as Aspergillus oryzae, yeast [such as Saccharomyces cerevisiae], and lactic acid bacteria, possessing various biological and pharmacological properties. In our previous experimental screening with thirty types of Rice Power® extracts, we observed that the 30th Rice Power® (Y30) extract promoted the survival of influenza A virus-infected Madin-Darby canine kidney (MDCK) cells. Therefore, to identify compounds for the development of novel anti-influenza drugs, we aimed to investigate whether the Y30 extract exhibits anti-influenza A virus activity. In the present study, we demonstrated that the Y30 extract strongly promoted the survival of influenza A H1N1 Puerto Rico 8/34 (A/PR/8/34), California 7/09, or H3N2 Aichi 2/68 (A/Aichi/2/68) viruses-infected MDCK cells and inhibited A/PR/8/34 or A/Aichi/2/68 viruses infection and growth in the co-treatment and pre-infection experiments. The pre-treatment of Y30 extract on MDCK cells did not induce anti-influenza activity in the cell. The Y30 extract did not significantly affect influenza A virus hemagglutination, and neuraminidase and RNA-dependent RNA polymerase activities. Interestingly, the electron microscopy experiment revealed that the Y30 extract disrupts the integrity of influenza A virus particles by permeabilizing the viral membrane envelope, suggesting that Y30 extract has a direct virucidal effect against influenza A virus. Furthermore, we observed that compared to the ethyl acetate (EtOAc) extract, the water extract of Y30 extract considerably promoted the survival of cells infected with A/PR/8/34 virus. These results indicated that more anti-influenza components were present in the water extract of Y30 extract than in the EtOAc extract. Our results highlight the potential of a rice extract fermented with A. oryzae and S. cerevisiae as an anti-influenza medicine and a drug source for the development of anti-influenza compounds.

SUBMITTER: Shoji M 

PROVIDER: S-EPMC7810313 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel aqueous extract from rice fermented with Aspergillus oryzae and Saccharomyces cerevisiae possesses an anti-influenza A virus activity.

Shoji Masaki M   Sugimoto Minami M   Matsuno Kosuke K   Fujita Yoko Y   Mii Tomohiro T   Ayaki Satomi S   Takeuchi Misa M   Yamaji Saki S   Tanaka Narue N   Takahashi Etsuhisa E   Noda Takeshi T   Kido Hiroshi H   Tokuyama Takaaki T   Tokuyama Takahito T   Tokuyama Takashi T   Kuzuhara Takashi T  

PloS one 20210115 1


Human influenza virus infections occur annually worldwide and are associated with high morbidity and mortality. Hence, development of novel anti-influenza drugs is urgently required. Rice Power® extract developed by the Yushin Brewer Co. Ltd. is a novel aqueous extract of rice obtained via saccharization and fermentation with various microorganisms, such as Aspergillus oryzae, yeast [such as Saccharomyces cerevisiae], and lactic acid bacteria, possessing various biological and pharmacological pr  ...[more]

Similar Datasets

| S-EPMC8398186 | biostudies-literature
| S-EPMC5029515 | biostudies-literature
| S-EPMC3306390 | biostudies-literature
| S-EPMC9695057 | biostudies-literature
| S-EPMC7023044 | biostudies-literature
| S-EPMC4176734 | biostudies-literature
| S-EPMC3485961 | biostudies-literature
| S-EPMC6273993 | biostudies-literature
| S-EPMC6045415 | biostudies-literature
| S-EPMC91276 | biostudies-literature